First human test for new pill form of drug

NCT ID NCT04481750

Summary

This was an early-stage study to check the safety and see how the body processes a new oral form of a drug called edaravone. It involved 74 healthy adult male volunteers who took single or multiple doses. The main goals were to see if the drug caused any side effects and to measure how much of it got into the bloodstream and how long it stayed.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site

    Osaka, Japan

Conditions

Explore the condition pages connected to this study.